The closing price of Acadia Healthcare Company Inc (NASDAQ: ACHC) was $80.31 for the day, down -0.27% from the previous closing price of $80.53. In other words, the price has decreased by -$0.22 from its previous closing price. On the day, 1044225 shares were traded.
Ratios:
Our analysis of ACHC’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 74.07 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 193.98. For the most recent quarter (mrq), Quick Ratio is recorded 0.67 and its Current Ratio is at 0.67. In the meantime, Its Debt-to-Equity ratio is 0.54 whereas as Long-Term Debt/Eq ratio is at 0.52.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on March 06, 2024, initiated with a Overweight rating and assigned the stock a target price of $100.
On April 21, 2023, Cantor Fitzgerald started tracking the stock assigning a Neutral rating and target price of $83.
Deutsche Bank Downgraded its Hold to Sell on April 20, 2023, whereas the target price for the stock was revised from $75 to $63.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 05 ’24 when Miquelon Wade D sold 2,203 shares for $85.39 per share. The transaction valued at 188,114 led to the insider holds 46,074 shares of the business.
Gregg Vicky B sold 2,500 shares of ACHC for $213,900 on Mar 04 ’24. The Director now owns 26,851 shares after completing the transaction at $85.56 per share. On Dec 13 ’23, another insider, OSTEEN DEBRA K, who serves as the Director of the company, sold 35,000 shares for $77.67 each. As a result, the insider received 2,718,450 and left with 675,833 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHC now has a Market Capitalization of 7.41B and an Enterprise Value of 8.81B. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.53 while its Price-to-Book (P/B) ratio in mrq is 2.63. Its current Enterprise Value per Revenue stands at 3.01 whereas that against EBITDA is 46.57.
Stock Price History:
Over the past 52 weeks, ACHC has reached a high of $87.77, while it has fallen to a 52-week low of $66.49. The 50-Day Moving Average of the stock is 82.69, while the 200-Day Moving Average is calculated to be 76.21.
Shares Statistics:
ACHC traded an average of 494.23K shares per day over the past three months and 605.1k shares per day over the past ten days. A total of 91.26M shares are outstanding, with a floating share count of 89.57M. Insiders hold about 2.94% of the company’s shares, while institutions hold 101.14% stake in the company. Shares short for ACHC as of Feb 29, 2024 were 2.78M with a Short Ratio of 5.62, compared to 3.22M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.01% and a Short% of Float of 3.10%.
Earnings Estimates
The firm’s stock currently is rated by 12 analysts. On average, analysts expect EPS of $0.8 for the current quarter, with a high estimate of $0.84 and a low estimate of $0.7, while EPS last year was $0.75. The consensus estimate for the next quarter is $0.95, with high estimates of $1.01 and low estimates of $0.87.
Analysts are recommending an EPS of between $3.69 and $3.21 for the fiscal current year, implying an average EPS of $3.55. EPS for the following year is $4.04, with 12 analysts recommending between $4.26 and $3.8.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 11 analysts. It ranges from a high estimate of $782.08M to a low estimate of $767.2M. As of the current estimate, Acadia Healthcare Company Inc’s year-ago sales were $704.27M, an estimated increase of 10.60% from the year-ago figure.
A total of 11 analysts have provided revenue estimates for ACHC’s current fiscal year. The highest revenue estimate was $3.26B, while the lowest revenue estimate was $3.2B, resulting in an average revenue estimate of $3.22B. In the same quarter a year ago, actual revenue was $2.93B, up 10.00% from the average estimate. Based on 11 analysts’ estimates, the company’s revenue will be $3.54B in the next fiscal year. The high estimate is $3.68B and the low estimate is $3.49B. The average revenue growth estimate for next year is up 9.90% from the average revenue estimate for this year.
